HIMSS14: FDA Official Responds to Criticism Over Mobile App Approval Process
Responding to criticism that the U.S. Food and Drug Administration's regulatory approval process is lagging behind software development cycles, the FDA is standing behind the timeframes its takes the agency to review and approve mobile medical applications. Speaking at a HIMSS14 pre-conference sympo